Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Sebök

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Orvosi Hetilap|April 24, 1988
[Torpid leg ulcer and amyloidosis]T Hrabovszky, F Baranyay, A Schmelás, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|September 27, 2001
[Bilateral, asymmetric herpes zoster (herpes zoster duplex asymmetricus)]Z Csontos, B Sebök, E Karg, et al.
European Journal of Pharmacology|January 3, 1994
Antiproliferative and cytotoxic profiles of antipsoriatic fumaric acid derivatives in keratinocyte culturesB Sebök, B Bonnekoh, J Geisel, et al.
Orvosi Hetilap|April 29, 1998
[Angiolymphoid hyperplasia with eosinophilia]B Sebök, I Bátai, B Anga, et al.
Skin Pharmacology and Applied Skin Physiology|October 5, 2001
Enhancement of the antiparakeratotic potency of calcitriol and tacalcitol in liposomal preparations in the mouse tail testJ N Körbel, B Sebök, M Kerényi, et al.
Skin Pharmacology : the Official Journal of the Skin Pharmacology Society|January 1, 1996
Effect of fumaric acid, its dimethylester, and topical antipsoriatic drugs on epidermal differentiation in the mouse tail modelB Sebök, T Szabados, M Kerényi, et al.
Orvosi Hetilap|April 3, 1988
[Treatment of skin graft donor sites and second degree burns with epidermal cell suspension--initial experience]B Sebök, Z Török, E Karg, et al.
The Journal of Investigative Dermatology|January 1, 1995
Up-regulation of keratin 17 expression in human HaCaT keratinocytes by interferon-gammaB Bonnekoh, C Huerkamp, A Wevers, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Orvosi Hetilap|April 24, 1988
[Torpid leg ulcer and amyloidosis]T Hrabovszky, F Baranyay, A Schmelás, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|September 27, 2001
[Bilateral, asymmetric herpes zoster (herpes zoster duplex asymmetricus)]Z Csontos, B Sebök, E Karg, et al.
European Journal of Pharmacology|January 3, 1994
Antiproliferative and cytotoxic profiles of antipsoriatic fumaric acid derivatives in keratinocyte culturesB Sebök, B Bonnekoh, J Geisel, et al.
Orvosi Hetilap|April 29, 1998
[Angiolymphoid hyperplasia with eosinophilia]B Sebök, I Bátai, B Anga, et al.
Skin Pharmacology and Applied Skin Physiology|October 5, 2001
Enhancement of the antiparakeratotic potency of calcitriol and tacalcitol in liposomal preparations in the mouse tail testJ N Körbel, B Sebök, M Kerényi, et al.
Skin Pharmacology : the Official Journal of the Skin Pharmacology Society|January 1, 1996
Effect of fumaric acid, its dimethylester, and topical antipsoriatic drugs on epidermal differentiation in the mouse tail modelB Sebök, T Szabados, M Kerényi, et al.
Orvosi Hetilap|April 3, 1988
[Treatment of skin graft donor sites and second degree burns with epidermal cell suspension--initial experience]B Sebök, Z Török, E Karg, et al.
The Journal of Investigative Dermatology|January 1, 1995
Up-regulation of keratin 17 expression in human HaCaT keratinocytes by interferon-gammaB Bonnekoh, C Huerkamp, A Wevers, et al.
Pageof 2